RAPT Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
RAPT Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • RAPT Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.67M, a 45.9% decline year-over-year.
  • RAPT Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.55M, a 17.2% increase year-over-year.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.3M, a 424% increase from 2022.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.96M, a 39040% increase from 2021.
  • RAPT Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5K, a 99.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.3M +$8.31M +424% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $1.96M +$1.95M +39040% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $5K -$1.31M -99.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $1.31M +$20K +1.55% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $1.29M +$492K +61.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $800K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.